Zmax Pediatric Vs Adult Concentration For The Treatment Of Acute Otitis Media

NCT00360100 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2011-05-17

No results posted yet for this study

Summary

Assess tolerability of different dosing formulations (adult versus pediatric).

Conditions

  • Otitis Media

Interventions

DRUG

Zmax

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
3 Months
Max Age
48 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-08-31
Completion
2006-12-31

Countries

  • United States
  • Argentina
  • Chile
  • Costa Rica
  • Dominican Republic
  • Guatemala
  • Panama

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00360100 on ClinicalTrials.gov